Onego Bio
PrivateLast Round
Series A
Extension
Jul 17, 2024
Est. Valuation
$84.8M
Total Funding Raised
$70.8M
Company Overview
Onego Bio is a food-biotech company that produces animal-free egg protein through precision fermentation.
Sector
Energy & Sustainability
Verticals
Biotechnology, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Onego Bio Comparables
Compare Onego Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| The EVERY Company | 85% | |
| Revyve | 84% | |
| PoLoPo | 81% |
Onego Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 17, 2024 | ||||
| Series A | Apr 2, 2024 | ||||
| Grant | Sep 7, 2022 | ||||
| Seed | Feb 22, 2022 |
Key People
Founding team and executive leadership
Onego Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agronomics Limited | Series A, Seed |
| European Innovation Council Fund | Series A Extension |
| Tesi | Series A |
| European Commission (Horizon Europe) | Series A Extension |
| Business Finland | Grant, Series A |
| Holdix | Series A |
| EIT Food | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 9, 2026
Collaborating with Sigma Foods on egg-free protein solutions.
- Feb 4, 2026
Dr. Antti Vasara appointed to the board of directors.
Recent news
Latest coverage and updates
- expands_facilitiesOct 13, 2026
Onego Bio Ltd plans a production facility in Wisconsin.
- files_suit_againstOct 11, 2026
A Delaware court dismisses Onego Bio Ltd's lawsuit against EVERY Co. on Oct 9th '26, ending the case filed in Fall '25 over ovalbumin patent validity, alleged infringement, licensing fees, and tortious interference.
- has_issues_withOct 11, 2026
Onego Bio Ltd faces a dispute over whether it infringes a "foundational" patent in Delaware on Oct 9th '26
Onego Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Onego Bio's valuation, stock price, and market status.
Is Onego Bio a public or private company?
Onego Bio is a private company.
What is the current stock price of Onego Bio?
Onego Bio is a private company, so its shares have no public market price. Caplight tracks Onego Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Onego Bio worth (valuation)?
Onego Bio's valuation is estimated at $84.8M based on funding round data.
Can I buy Onego Bio stock?
Onego Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Onego Bio's last funding round?
Onego Bio's most recent funding round was Series A Extension on July 17, 2024.
Who are the main investors in Onego Bio?
Key investors in Onego Bio include Agronomics Limited, European Commission (Horizon Europe), NordicNinja VC.
Will Onego Bio IPO soon?
No public IPO plans have been announced for Onego Bio.
How can I track Onego Bio secondary market activity?
Caplight tracks bids, offers, and trades in Onego Bio's shares on secondary markets.